Abstract
The Goeckerman regimen is a unique combination therapy of UVB light and application of crude coal tar for the treatment of psoriasis, eczema, prurigo nodularis, and chronic pruritus. Coal tar is speculated to be an anti-inflammatory and a photosensitizer that can increase the effectiveness of phototherapy. In the Goeckerman regimen, patients first undergo UVB phototherapy per protocol. Then their body is covered in crude coal tar under plastic occlusion for 4–5 h. This is repeated daily, 5 days per week, for approximately 6 weeks. The efficacy of Goeckerman is superior to most other available therapies. For example, 100% of patients with severe psoriasis achieve 75% improvement or better from baseline by 12 weeks. Side effects include those of phototherapy (erythema, burning, and tanning), as well as irritation and folliculitis from tar products.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Gupta R, Debbaneh M, Butler D, et al. The Goeckerman regimen for the treatment of moderate to severe psoriasis. J Vis Exp. 2013;77:e50509.
Dennis M, Bhutani T, Koo J, Liao W. Goeckerman therapy for the treatment of eczema: a practical guide and review of efficacy. J Dermatolog Treat. 2013;24(1):2–6.
Sorenson E, Levin E, Koo J, Berger TG. Successful use of a modified Goeckerman regimen in the treatment of generalized prurigo nodularis. J Am Acad Dermatol. 2015;72(1):40–2.
Nakamura M, Koo J, Bhutani T. Uremic pruritus treated successfully with the Goeckerman Program. Dermatol Online J. 2016;22(8):19.
Goeckerman WH. The treatment of psoriasis. Northwest Med. 1925;24:229–30.
Parrish JA, Morison WL, Gonzalez E, Krop TM, White HA, Rosario R. Therapy of psoriasis by tar photosensitization. J Invest Dermatol. 1978;70(2):111–2.
Zhu TH, Nakamura M, Abrouk M, et al. The patient’s guide to psoriasis treatment: Part 4. Goeckerman Therapy. Dermatol Ther. 2016;6(3):333–9.
Lee E, Koo J. Modern modified ‘ultra’ Goeckerman therapy: a PASI assessment of a very effective therapy for psoriasis resistant to both prebiologic and biologic therapies. J Dermatolog Treat. 2005;16(2):102–7.
Kim IH, West CE, Kwatra SG, Feldman SR, O’Neill JL. Comparative efficacy of biologics in psoriasis: a review. Am J Clin Dermatol. 2012;13:365–74.
Koo J, Lebwohl M. Duration of remission of psoriasis therapies. J Am Acad Dermatol. 1999;41(1):51–9.
Chern E. Positive effect of modified Goeckerman regimen on quality of life and psychosocial distress in moderate and severepsoriasis. Acta Derm Venereol. 2011;91:447–51.
Roelofzen J, Aben K, Oldenhof U, et al. No increased risk of cancer after coal tar treatment in patients with psoriasis or eczema. J Invest Dermatol. 2009;130(4):953–61.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Koo, J., Nakamura, M. (2017). Goeckerman Therapy for the Treatment of Severe Generalized Psoriasis. In: Clinical Cases in Phototherapy. Clinical Cases in Dermatology. Springer, Cham. https://doi.org/10.1007/978-3-319-51599-1_4
Download citation
DOI: https://doi.org/10.1007/978-3-319-51599-1_4
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-51598-4
Online ISBN: 978-3-319-51599-1
eBook Packages: MedicineMedicine (R0)